StockNews.AI
JNJ
StockNews.AI
21 days

Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case

1. A Boston jury awarded $42.6M to a plaintiff alleging mesothelioma from JNJ's baby powder. 2. This verdict is believed to be the largest in Massachusetts for such a case.

2m saved
Insight
Article

FAQ

Why Very Bearish?

The substantial verdict could signal increased legal risks for JNJ, reminiscent of past asbestos-related suits affecting stock price negatively.

How important is it?

The large verdict could set a precedent, intensifying scrutiny and potential future claims against JNJ.

Why Long Term?

The ongoing legal challenges related to asbestos could lead to further financial liabilities and affect JNJ's reputation over time.

Related Companies

PGBMYUNH
BOSTON--(BUSINESS WIRE)--A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell's mesothelioma was directly caused by the company's iconic, asbestos-laced baby powder. The jury awarded $42,609,300, making it what lawyers believe to be the largest mesothelioma verdict in Massachusetts history. During the two-week trial, jurors heard compelling arguments from Dean Omar Branham Shirley attorneys Aaron Ch.

Related News